Modified hemoglobin-based blood substitutes: Crosslinked, recombinant and encapsulated hemoglobin

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 233-241

  Chang, T M S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; CATALASE; HEMOGLOBIN; POLYMER; PYRIDOXYLPOLYHEMOGLOBIN; SUPEROXIDE DISMUTASE;

CONFERENCE PAPER; CONJUGATION; CROSS LINKING; ENCAPSULATION; ERYTHROCYTE; ESCHERICHIA COLI; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY;

EID: 0031851041     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05425.x     Document Type: Conference Paper

References (32)

1. Perutz, MF. Stereochemical mechanism of oxygen transport by hemoglobin. Proc R Soc Lond B, 208:135, 1980.
2. Savitsky, JP, J Doozi, J Black, JD Arnold . A clinical safety trial of stroma free hemoglobin. Clin Pharm Ther, 23:73, 1978.
3. Chang, IMS: Blood Substitutes: Principles, Methods, Products and Clinical Trials. Vol. 1 Basel Karger/Texas Landes. 1997
4. Chang, TMS. Hemoglobin corpuscles. Report of a research project of B.Sc. Honours Physiology, McGill University, 1-25, 1957. Medical Library, McIntyre Building, McGill University,1957 (reprinted in "30th Anniversary in Artificial Red Blood Cell Research" Biomaterials, Artificial Cells and Artificial1 Organs 16:1-9, 1988).
5. Chang, TMS. Semipermeable microcapsules. Science 146(3643):524, 1964.
6. Bunn, HF, JH Jandl. The renal handling of hemoglobin. Trans Assoc Am Physicians 81:147, 1968.
7. Chang, TMS. Stabilization of enzyme by microencapsulation with a concentrated protein solution or by crosslinking with glutaraldehyde. Biochem Biophys. Res Com, 44:1531-1533, 1971.
8. Benesch, R, RE Benesch, S Yung , and R Edalji. Hemoglobin covalently bridged across the polyphosphate binding site. Biochem Biophys Res Commun 63:1123, 1975.
9. Could, SA, F.A Moore et al. Clinical Utility of Human polymerized hemoglobin as a Blood Substitute after Acute Trauma and Urgent Surgery. J. Trauma: Injury, Infection and Critical Care 43: 325-332, 1997
10. Gould, SA, LR Sehgal, HL Sehgal, R DeWoskin, GS Moss, The clinical development of human polymerized hemoglobin, in Blood Substitutes: Principles, Methods, Products and Clinical Trials. Vol.2 (Chang, TMS, ed.) vol 2 ,pp 12-28 Basel Karger/Texas, Landes. 1998
11. Pearce, LB, MS Gawryl, Overview of pre-clinical and clinical efficacy of Biopure's HBOCs in Blood Substitutes: Principles, Methods, Products and Clinical Trials. (Chang, TMS, ed.) vol 2, pp82-98 Basel Karger/Texas Landes, 1998
12. Hsia JC. o-Raffinose polymerized hemoglobin as red blood cell substitute. Biomaterial Artificial Cells and Immobilization Biotechnology, 19:402, 1991.
13. Adamson, JG & C. Moore, Hemolink TM, an o-Raffinose crosslinked hemoglobin-based oxygen carrier , in Blood Substitutes: Principles, Methods, Products and Clinical Trials (Chang, TMS, ed.) vol 2 pp62-79 Basel Karger/Texas Landes, 1998
14. Walder, JA, RH Zaugg, RY Walder, JM Steele, and IM Klotz IM. Diaspirins that cross-link alpha chains of hemoglobin: Bis(3,5dibromosalicyl) succinate and bis(3,5dibormosalicyl)fumarate. Biochemistry 18:4265-4270, 1979.
15. Nelson, DJ, Blood and HemAssistTM (DCLHb): Potentially A complementary therapeutic team, in Blood Substitutes: Principles, Methods, Products and Clinical Trials. Vol.2 (Chang, IMS, ed.) pp39-57, Basel Kar- get/Texas Landes, 1998
16. Hoffman, SJ, DL Looker, JM Roehrich et al. Expression of fully functional tetrameric human hemoglobin in escherichia coli. Proc. Natl. Acad. Sci. USA, 87:8521-8525, 1990.
17. Winslow RM. Blood Substitutes in development. Ashley Publications Ltd, 27-37, 1996
18. Caspari, RF, Recent Progress in the development of Optro (Recombinant Human Hemoglobin, rHb1.1) Abstract, International Symposium on Blood Substitutes, Tokyo., 1997.
19. Chang, TMS. Ph.D. Thesis, McGill University, 1965.
20. Wong, JT. Rightshifted dextran hemoglobin as blood substitute. Biomaterials, Artificial Cells and Artificial Organs. 16:237-245, 1988.
21. Iwashita, Y, A Yabuki, K Yamaji, K Iwasaki, T Okami, C Hirati, and K Kosaka. A new re- suscitation fluid "Stabilized hemoglobin" preparation and Characteristics. Biomaterials, Artificial Cells and Artificial Organs, 16:271-280, 1988.
22. Shorr, RG, AT Viau, and A Abuchowski. Phase IB safety evaluation of PEG hemoglobin as an adjuvant to radiation therapy in human cancer patients. Artficial Cells,Blood Substitutes and Immbolization Biotechnology, an International Journal, 24:(abstracts issue) 407, 1996.
23. Lemon, DD, Dohertym, DH, Curry, SR, Mathews AJ, Doyle MP, Fattor TJ & Olson JS. Abstract volume for VI International Symposium on Blood Substitutes, Artificial Cells, & Immobilization Biotechnology, An International Journal, Volume 24, issue 4, 1996
24. Sekiguchi, S. Studies on the quality control of stroma free hemoglobin. Biomaterials, Artifi- cial Cells and Immobilization Biotechnology, 20:407-414, 1992.
25. Alayash, AI, BA Brockner-Ryan, LL McLeod, DW Goldman & RE Cashon (1998), "Cell-free hemoglobin and tissue oxidants: probing the mechanisms of hemoglobin cytotoxicity", in Blood Substitutes: Principles, Methods, Products and Clinical Trials. Vol.2 (Chang, TMS, ed.) pp157-174, Basel Karger/Texas Landes, 1998
26. Chang, TMS, F. D'Agnillo and S. Razack: A second generation hemoglobin based blood substitute with antioxidant activities, in Blood Substitutes: Principles, Methods, Products and Clinical Trials. Vol.2 (Chang, TMS, ed.) pp!78-186, Basel Karger/Texas Landes, 1998
27. Chang, TMS. Artificial cells. Monograph. Charles C Thomas, Springfield, IL, 1972.
28. Chang, TMS, and Poznansky MJ, Semipermeable microcapsules containing catalase for enzyme replacement in acatalsaemic mice. Nature 218(5138):242-245.1968.
29. Djordjevich, L, and IF Miller. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp Hematol, 8:584, 1980.
30. Rudolph, AS, R Rabinovici and GZ Feuerstein (eds) (1997) Red Blood Cell Substitutes. Marcel Dekker, Inc., N.Y.
31. Tsuchida, E. (ed.)(1995) Artificial Red Cells, John Wiley & Sons, New York, N.Y.
32. Chang, IMS and WP Yu Nanoencapsulation of hemoglobin and red blood cell enzymes based on nanotechnology and biodegradable polymer, in Blood Substitutes: Principles, Methods, Products and Clinical Trials. Vol.2 (Chang, TMS, ed.) pp216-231, Basel Karger/Texas Landes, 1998